Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-01-03 @ 1:38 AM
Study NCT ID:
NCT02287467
Status:
COMPLETED
Last Update Posted:
2019-11-14
First Post:
2014-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2018-06-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-06
First Submit QC Date:
None
Study First Post Date:
2014-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-20
Results First Submit QC Date:
None
Results First Post Date:
2019-11-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-11
Last Update Post Date:
2019-11-14
Last Update Post Date Type:
ACTUAL